| Today,the situation at home and abroad is becoming increasingly complex and severe,and enterprises face many difficulties in operation.It is very important to have freely controlled cash flow,so the concept of cash flow first has been deeply rooted in the hearts of people.The amount of cash and the level of management directly determine the survival and future sustainability of enterprises.With the high attention paid by the state to the development of medical and health care,and the substantial support given in infrastructure investment and policy,China’s pharmaceutical manufacturing industry has been in a rapid development stage.However,the rapid expansion of enterprises has affected the quality of cash flow,thereby affecting the sustainable development of enterprises.Therefore,this paper takes the cash flow of YL Pharmaceutical Company as the topic for research and proposes innovative countermeasures,so as to improve the quality of cash flow and management level of the enterprise,point out the direction for the future financial control of the enterprise,reduce the financial risk of the enterprise,and provide reference for other pharmaceutical enterprises.After sorting out the relevant data and literature on the cash flow of YL Pharmaceutical Company,this paper adopts the financial ratio analysis method,analyzes the cash flow data of YL Pharmaceutical Company in the past six years based on the quality of cash flow,and conducts a longitudinal analysis of each indicator in five aspects of the cash flow structure,liquidity,cash acquisition ability,financial flexibility,and income quality of YL Pharmaceutical Company.Through analysis,it is found that YL Pharmaceutical Company has problems such as large amount of operating cash occupied by inventory,long payback period of accounts receivable,excessive proportion of sales expenses,etc.,and is vulnerable to the impact of external environment and industry characteristics.The main reasons are: the cash flow liquidity of products and raw materials becomes worse due to seasonal impact;Long investment recovery cycle and loose credit policy lead to weak cash flow ability;The product innovation is slow,the R&D cycle is too long,and excessive reliance on increasing sales expenses to increase income affects the quality of cash flow;In addition,the impact of epidemic situation at home and abroad continues,which leads to a certain risk in the cash flow of YL Pharmaceutical Company.Therefore,this paper proposes the following innovative countermeasures on the above issues: First,YL Pharmaceutical Company should accurately predict supply and demand,strengthen the recovery of accounts receivable,and improve the management level of accounts receivable;Secondly,control the cost and period expenses of the enterprise,and strengthen the internal management of the enterprise;At the same time,predict the optimal cash holdings of enterprises,strengthen risk management and control,and establish a risk reserve system;Finally,improve the risk prevention and control ability of the company’s management personnel,financial personnel,procurement personnel and other personnel,enhance the overall anti risk ability of the enterprise,promote the good operation of the enterprise’s cash flow,and enable the enterprise to better participate in the market competition. |
